Exicure, Inc. (XCUR) stock
XCURNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.04−0.04 (-3.70%)
Close on Nov 18, 2026Market cap $6.81MP/E –Yield –
Exicure operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Exicure's operating cash flow for the twelve months ending Jun 30, 2026 was -$6.70M. For fiscal 2025 it was -$8.56M. The highest annual figure on record is $1.32M in fiscal 2019.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$8.56M | – |
| FY2024 | Dec 31, 2024 | -$2.91M | – |
| FY2023 | Dec 31, 2023 | -$10.36M | – |
| FY2022 | Dec 31, 2022 | -$35.66M | – |
| FY2021 | Dec 31, 2021 | -$34.82M | – |
| FY2020 | Dec 31, 2020 | -$39.27M | -3081.8% |
| FY2019 | Dec 31, 2019 | $1.32M | – |
| FY2018 | Dec 31, 2018 | -$19.49M | – |
| FY2017 | Dec 31, 2017 | -$19.79M | – |
| FY2016 | Dec 31, 2016 | -$5.05M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$887.00K | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.14M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.15M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.53M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.28M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.60M | – |
| Q4 FY2024 | Dec 31, 2024 | -$845.00K | – |
| Q3 FY2024 | Sep 30, 2024 | -$449.00K | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.17M | – |
| Q1 FY2024 | Mar 31, 2024 | -$450.00K | – |
| Q4 FY2023 | Dec 31, 2023 | -$816.00K | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.41M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.81M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.32M | – |
| Q4 FY2022 | Dec 31, 2022 | -$7.28M | – |
| Q3 FY2022 | Sep 30, 2022 | -$6.55M | -234.6% |
| Q2 FY2022 | Jun 30, 2022 | -$9.08M | – |
| Q1 FY2022 | Mar 31, 2022 | -$12.76M | – |
| Q4 FY2021 | Dec 31, 2021 | -$13.80M | – |
| Q3 FY2021 | Sep 30, 2021 | $4.86M | – |
| Q2 FY2021 | Jun 30, 2021 | -$11.08M | – |
| Q1 FY2021 | Mar 31, 2021 | -$14.81M | – |
| Q4 FY2020 | Dec 31, 2020 | -$11.81M | -177.0% |
| Q3 FY2020 | Sep 30, 2020 | -$8.65M | – |
| Q2 FY2020 | Jun 30, 2020 | -$10.97M | – |
| Q1 FY2020 | Mar 31, 2020 | -$7.85M | – |
| Q4 FY2019 | Dec 31, 2019 | $15.33M | – |
| Q3 FY2019 | Sep 30, 2019 | -$5.02M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.98M | – |
| Q1 FY2019 | Mar 31, 2019 | -$4.01M | – |
| Q4 FY2018 | Dec 31, 2018 | -$5.96M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.19M | -174.5% |
| Q2 FY2018 | Jun 30, 2018 | -$4.68M | – |
| Q1 FY2018 | Mar 31, 2018 | -$4.65M | – |
| Q4 FY2017 | Dec 31, 2017 | -$5.34M | – |
| Q4 FY2016 | Dec 31, 2016 | $5.63M | – |
See a number that looks wrong?